Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026

Go back to Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026
(NASDAQ: FULC) Delayed: 3.77 +0.07 (1.89%)
Previous Close $3.70    52 Week High
Open $3.69    52 Week Low
Day High $3.89    P/E N/A 
Day Low $3.63    EPS
Volume 2,867,425